Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist / β2-adrenoceptor agonist (MABA) molecule
In conclusion, these studies suggest that LAS190792 is a dual-acting muscarinic antagonist β2-adrenoceptor agonist that has the potential to be a next generation bronchodilator with long-lasting effects and wide safety margin in humans.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Drugs & Pharmacology | Inderal | Israel Health | Middle East Health | Respiratory Medicine | Spiriva | Study | Tiotropium